MiT family translocation renal cell carcinoma treated by surgery combined with targeted and immunotherapy: Report of two cases

Asian J Surg. 2023 Nov;46(11):4821-4822. doi: 10.1016/j.asjsur.2023.05.120. Epub 2023 Jul 5.

Authors

Dan Zeng¹, Hong-Jin Shi¹, Bing Hai², Jin-Song Zhang³

Affiliations

¹ Urology Department of the Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan Province, China.
² Department of Respiratory and Critical Care Medicine of the Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan Province, China.
³ Urology Department of the Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan Province, China. Electronic address: 945933392zjs@sina.com.

PMID: 37419792
DOI: 10.1016/j.asjsur.2023.05.120

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Carcinoma, Renal Cell* / pathology
Humans
Immunotherapy
Kidney Neoplasms* / pathology
Translocation, Genetic